SOFOKAST TABLET 28'S

No, SOFOKAST TABLET 28'S is not recommended as a monotherapy for hepatitis C. It is typically used in combination with other antiviral medications. The specific combination therapy will depend on factors such as the HCV genotype, previous treatment history, and the presence of liver cirrhosis.

SOFOKAST TABLET 28'S primarily treats individuals already infected with hepatitis C. While it can cure the infection and reduce the viral load, it does not provide direct protection against acquiring hepatitis C or prevent transmission to others. Prevention of hepatitis C transmission involves practicing safe behaviors such as using barrier methods during sexual activity, avoiding sharing needles or other drug paraphernalia, and taking precautions to prevent blood-to-blood contact.

Yes, SOFOKAST TABLET 28'S can be used in patients with liver cirrhosis. It has shown efficacy and safety in patients with compensated and decompensated liver cirrhosis. However, careful monitoring and individualized treatment plans may be required for patients with advanced liver disease.

Weight gain is not a commonly reported side effect of SOFOKAST TABLET 28'S. However, individual responses to medications can vary, and some patients may experience changes in weight during or after treatment.

Yes, SOFOKAST TABLET 28'S can be used in elderly patients. Age alone is not a contraindication for its use. However, elderly patients may have a higher likelihood of comorbidities and may be taking multiple medications, which can increase the risk of drug interactions.

Yes, SOFOKAST TABLET 28'S can be used in patients who are co-infected with both hepatitis C virus (HCV) and HIV. However, the choice may depend on the specific antiretroviral therapy used to treat HIV. Some antiretroviral medications can interact with it, potentially affecting the levels of both drugs in the body. It is crucial to work closely with healthcare providers to cure HCV and HIV co-infection to ensure optimal treatment outcomes.

Common side effects may include fatigue, headache, nausea, insomnia, diarrhea, itching, decreased appetite, and rash or skin reactions. Serious side effects are rare, including hepatitis B reactivation in co-infected individuals, serious bradycardia when combined with Amiodarone, and allergic reactions.

There are no known significant interactions of SOFOKAST TABLET 28'S with other drugs.

Before starting treatment, inform your healthcare provider if you have a history of hepatitis B, your liver function, and HBV DNA levels (an indicator of hepatitis B infection in the blood) will closely monitor during treatment. Be aware of the risk of serious bradycardia when SOFOKAST TABLET 28'S is combined with Amiodarone, and inform your healthcare provider if you are taking this medication. Any signs of allergic reactions, such as difficulty breathing or swelling, should be reported immediately. Pregnant and breastfeeding individuals should discuss the potential risks and benefits with their healthcare provider. Adhere to the prescribed treatment regimen and attend regular check-ups to monitor treatment response.

SOFOSBUVIR is the molecule/combination used for making SOFOKAST TABLET 28'S.

SOFOKAST TABLET 28'S is an antiviral medication used to treat infectious diseases like Hepatitis C.

SOFOKAST TABLET 28'S is prescribed in Gastroenterology for treating liver related issues caused due to Hepatitis C infection.